Overview

Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Akershus
Collaborators:
AstraZeneca
Haukeland University Hospital
Treatments:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rosuvastatin Calcium